Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionRoyce & Associates Lp
ManagerChuck Royce
Latest Disclosed Ownership1,061,448 shares
Latest Disclosed Value $ 24,731,738
Royce & Associates Lp reports 15.34% increase in ownership of HVE / Innoviva, Inc.

On May 12, 2026 - Royce & Associates Lp filed a 13F-HR form disclosing ownership of 1,061,448 shares of Innoviva, Inc. (DE:HVE) valued at $21,228,960 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 920,317 shares of Innoviva, Inc.. This represents a change in shares of 15.34% during the quarter. The current value of the position is $20,379,802 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INNOVIVA COM 45781M101 1,061,448 141,131 15.34 24,732 34.43 0.2441
2026-02-09 2025-12-31 13F INNOVIVA COM 45781M101 920,317 414,411 81.91 18,397 99.27 0.1866
2025-11-12 2025-09-30 13F INNOVIVA COM 45781M101 505,906 437,654 641.23 9,233 573.38 0.0921
2025-08-11 2025-06-30 13F INNOVIVA COM 45781M101 68,252 -1,872 -2.67 1,371 7.87 0.0141
2025-05-06 2025-03-31 13F INNOVIVA COM 45781M101 70,124 10,499 17.61 1,271 22.92 0.0138
2025-02-10 2024-12-31 13F INNOVIVA COM 45781M101 59,625 1,717 2.97 1,034 -7.51 0.0096
2024-11-06 2024-09-30 13F INNOVIVA COM 45781M101 57,908 13,414 30.15 1,118 53.36 0.0102
2024-08-13 2024-06-30 13F INNOVIVA COM 45781M101 44,494 -24,612 -35.61 730 -30.77 0.0068
2024-05-13 2024-03-31 13F INNOVIVA COM 45781M101 69,106 -15,071 -17.90 1,053 -22.00 0.0094
2024-02-12 2023-12-31 13F INNOVIVA COM 45781M101 84,177 -32,373 -27.78 1,350 -10.77 0.0125
2023-11-09 2023-09-30 13F INNOVIVA COM 45781M101 116,550 -1,814 -1.53 1,514 0.46 0.0154
2023-08-07 2023-06-30 13F INNOVIVA COM 45781M101 118,364 944 0.80 1,507 14.09 0.0146
2023-05-23 2023-03-31 13F/A-1 INNOVIVA COM 45781M101 117,420 18,054 18.17 1,321 0.30 0.0132
2023-05-04 2023-03-31 13F INNOVIVA COM 45781M101 117,420 18,054 1 0.0132
2023-05-23 2022-12-31 13F/A-1 INNOVIVA COM 45781M101 99,366 18,155 22.36 1,317 39.55 0.0138
2023-02-13 2022-12-31 13F INNOVIVA COM 45781M101 99,366 18,155 1 0.0138
2022-11-03 2022-09-30 13F INNOVIVA COM 45781M101 81,211 2,914 3.72 943 -18.43 0.0107
2022-08-04 2022-06-30 13F INNOVIVA COM 45781M101 78,297 -2,192 -2.72 1,156 -25.75 0.0119
2022-05-05 2022-03-31 13F INNOVIVA COM 45781M101 80,489 -10,472 -11.51 1,557 -0.76 0.0132
2022-02-07 2021-12-31 13F INNOVIVA COM 45781M101 90,961 4,600 5.33 1,569 8.73 0.0117
2021-11-10 2021-09-30 13F INNOVIVA COM 45781M101 86,361 1,081 1.27 1,443 26.14 0.0108
2021-08-06 2021-06-30 13F INNOVIVA COM 45781M101 85,280 2,837 3.44 1,144 16.14 0.0079
2021-05-10 2021-03-31 13F INNOVIVA COM 45781M101 82,443 3,728 4.74 985 1.03 0.0066
2021-02-08 2020-12-31 13F INNOVIVA COM 45781M101 78,715 2,091 2.73 975 21.72 0.0081
2020-11-12 2020-09-30 13F INNOVIVA COM 45781M101 76,624 736 0.97 801 -24.51 0.0086
2020-08-07 2020-06-30 13F INNOVIVA COM 45781M101 75,888 206 0.27 1,061 19.21 0.0117
2020-05-12 2020-03-31 13F INNOVIVA COM 45781M101 75,682 -267 -0.35 890 -17.21 0.0121
2020-02-06 2019-12-31 13F INNOVIVA COM 45781M101 75,949 15,064 24.74 1,075 67.45 0.0096
2019-11-13 2019-09-30 13F INNOVIVA COM 45781M101 60,885 26,193 75.50 642 27.13 0.0059
2019-08-12 2019-06-30 13F INNOVIVA COM 45781M101 34,692 14,944 75.67 505 82.31 0.0046
2019-05-09 2019-03-31 13F INNOVIVA COM 45781M101 19,748 18,449 1,420.25 277 1,104.35 0.0023
2019-02-11 2018-12-31 13F INNOVIVA COM 45781M101 1,299 -615 -32.13 23 -20.69 0.0002
2018-11-13 2018-09-30 13F INNOVIVA COM 45781M101 1,914 719 60.17 29 81.25 0.0002
2018-08-09 2018-06-30 13F INNOVIVA COM 45781M101 1,195 522 77.56 16 45.45 0.0001
2018-05-14 2018-03-31 13F INNOVIVA COM 45781M101 673 -174 -20.54 11 -8.33 0.0001
2018-02-09 2017-12-31 13F INNOVIVA COM 45781M101 847 91 12.04 12 9.09 0.0001
2017-11-13 2017-09-30 13F INNOVIVA COM 45781M101 756 756 11 0.0001
2014-11-12 2014-09-30 13F THERAVANCE COM 88338T104 0 -4,300 -100.00 0 -100.00
2014-08-11 2014-06-30 13F THERAVANCE COM 88338T104 4,300 -18,600 -81.22 128 -81.95 0.0004
2014-05-12 2014-03-31 13F THERAVANCE COM 88338T104 22,900 22,900 709 0.0021
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.